The ratio of obestatin/AG was significantly higher in subjects with the cluster of four MetS risk factors compared to subjects without the cluster of four MetS risk factors by 3.8-fold (p = 0.001) (Fig. 2D). This evidence concerns the gene GHRL and metabolic syndrome.